Imugene’s other priority adenoviral delivery system products are the pig vaccine being developed under contract for Merial and the Porcine Reproductive and Respiratory Syndrome (PRRS) vaccine. Both are in the final stages of purification and in-house batch confirmation prior to international shipping for evaluation trials by major animal health companies. At Imugene’s insistence, license negotiations will be deferred to follow the completion of these trials to maximise the value of the licenses.
guess who merial is working with?, page-2
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.1¢ | 4.9¢ | $776.4K | 15.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6526158 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1499998 | 1 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |